TipRanks
Advertisement
Advertisement

IMNM Stock Latest News

Immunome initiated with a Hold at Stifel
The FlyImmunome initiated with a Hold at Stifel
5h ago
IMNM
Immunome announces IND clearance for IM-1340 in solid tumors
PremiumThe Fly
Immunome announces IND clearance for IM-1340 in solid tumors
13h ago
IMNM
Immunome initiated with a Buy at Alliance Global
PremiumThe Fly
Immunome initiated with a Buy at Alliance Global
10d ago
IMNM
Immunome price target raised to $35 from $31 at Wedbush
PremiumThe Fly
Immunome price target raised to $35 from $31 at Wedbush
1M ago
IMNM
Immunome: Advancing Pipeline and Strong Cash Runway Underpin Reiterated Buy Rating and Unchanged $40 Price Target
PremiumRatings
Immunome: Advancing Pipeline and Strong Cash Runway Underpin Reiterated Buy Rating and Unchanged $40 Price Target
2M ago
IMNM
Immunome reports Q2 EPS (65c), consensus (50c)
PremiumThe FlyImmunome reports Q2 EPS (65c), consensus (50c)
2M ago
IMNM
Immunome announces first patient dosed in Phase 1 IM-3050 trial
Premium
The Fly
Immunome announces first patient dosed in Phase 1 IM-3050 trial
2M ago
IMNM
FDA NDA Acceptance and Strong RINGSIDE Data Support Immunome Buy Rating and Unchanged $40 Price Target
Premium
Ratings
FDA NDA Acceptance and Strong RINGSIDE Data Support Immunome Buy Rating and Unchanged $40 Price Target
3M ago
IMNM
Immunome’s NDA for varegacestat in desmoid tumors accepted by FDA
PremiumThe Fly
Immunome’s NDA for varegacestat in desmoid tumors accepted by FDA
3M ago
IMNM
Analyst Brian Cheng Initiates Buy on Immunome, Citing Differentiated Pipeline and Compelling Risk‑Reward Profile
PremiumRatings
Analyst Brian Cheng Initiates Buy on Immunome, Citing Differentiated Pipeline and Compelling Risk‑Reward Profile
3M ago
IMNM
Immunome’s New Radiopharma Trial Puts IMNM on Early Oncology Watchlists
PremiumCompany Announcements
Immunome’s New Radiopharma Trial Puts IMNM on Early Oncology Watchlists
3M ago
IMNM
Immunome shareholders reaffirm board, auditor and pay policies
PremiumCompany Announcements
Immunome shareholders reaffirm board, auditor and pay policies
4M ago
8K
IMNM
Charles Zhu Doubles Immunome Price Target to $40 on ADC Pipeline Progress and Favorable Risk‑Reward Profile
PremiumRatingsCharles Zhu Doubles Immunome Price Target to $40 on ADC Pipeline Progress and Favorable Risk‑Reward Profile
4M ago
IMNM
Immunome announces first patient dosed in Phase 1 trial of IM-1617
Premium
The Fly
Immunome announces first patient dosed in Phase 1 trial of IM-1617
4M ago
IMNM
Immunome Reaffirmed at Buy as Varegacestat Data Underscore Competitive Edge; $40 Price Target Maintained
Premium
Ratings
Immunome Reaffirmed at Buy as Varegacestat Data Underscore Competitive Edge; $40 Price Target Maintained
4M ago
IMNM
Immunome announces Ringside trial met primary, secondary endpoints
PremiumThe Fly
Immunome announces Ringside trial met primary, secondary endpoints
4M ago
IMNM
Immunome price target raised to $37 from $36 at Truist
PremiumThe Fly
Immunome price target raised to $37 from $36 at Truist
4M ago
IMNM
Immunome initiated with an Overweight at Barclays
PremiumThe Fly
Immunome initiated with an Overweight at Barclays
4M ago
IMNM
Immunome Expands Oncology Pipeline With New Phase 1 IM-1617 Trial
PremiumCompany Announcements
Immunome Expands Oncology Pipeline With New Phase 1 IM-1617 Trial
4M ago
IMNM
Immunome price target lowered to $33 from $37 at Leerink
PremiumThe FlyImmunome price target lowered to $33 from $37 at Leerink
5M ago
IMNM
Immunome Price Target Maintained at $35 as Analyst Sees Best-in-Class Potential for Varegacestat in Desmoid Tumors
Premium
Ratings
Immunome Price Target Maintained at $35 as Analyst Sees Best-in-Class Potential for Varegacestat in Desmoid Tumors
5M ago
IMNM
Analyst Reiterates Buy on Immunome, Maintains $40 Price Target on Varegacestat Progress and Pipeline Upside
Premium
Ratings
Analyst Reiterates Buy on Immunome, Maintains $40 Price Target on Varegacestat Progress and Pipeline Upside
5M ago
IMNM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >